Telemetric and Holter ECG Warehouse (THEW)
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2008
- Initiating Organization: University of Rochester
- Initiator Type: Academia
- Disease focus:
Cardiovascular - Location: International
Abstract
The objective of the Telemetric and Holter ECG Warehouse (THEW) is to provide services to public, private, and any legal scientific organizations world-wide by fostering and distributing the resources (data and tools) needed to conduct ECG-related research activities. The THEW initiative deploys appropriate information technologies and computer processing power to benefit the overall scientific community. The THEW is a public/private partnership with the U.S. Food and Drug Administration (FDA) developed under the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute support and led by a Steering Committee consisting of staff members of the FDA, the NIH, and the University of Rochester (UR).
Sponsors & Partners
The objective of the Telemetric and Holter ECG Warehouse (THEW) is to provide access to continuous electrocardiographic data to for-profit and nonprofit organizations for the design and validation of analytic methods to advance the field of quantitative electrocardiography with a strong focus on cardiac safety.
The THEW hosts more than 3,700 digital 24-Holter ECG recordings from 13 independent studies. In addition to the ECGs, the repository includes patient information in a separate clinical database with content varying according to the study focus. The THEW database has been accessed by researchers from 37 universities and 16 corporations located in 16 countries worldwide. Twenty publications have been released primarily focusing on the development and validation of ECG-based technologies.
The THEW initiative is a nonprofit, 501(c)(3) organization hosted by the Heart Research Follow-up Program at the University of Rochester Medical Center.
Homepage |
University Medicine Berlin |
Harvard Medical School – Wyss Institute for Biologically Inspired Engineering |
Academy of Sciences of the Czech Republic |
Baskir State Pedagogical University |
Chinese Academy of Medical Sciences |
Chung-Yuan Christian University |
College of Veterinary Medicine, Cornell University |
Erasmus University Rotterdam |
FDA |
Henry M. Jackson Foundation |
Hospital Louis Pradel |
INSERM (France) |
Johns Hopkins University School of Medicine |
Karlsruhe Institute of Technology |
Long Beach Memorial Medical Center |
Masonic Medical Research Laboratory |
Massachusetts General Hospital |
National Polytechnic Institute of Mexico |
NIH |
Oklahoma State University – Center for Health Sciences |
Oxford University |
Polytechnic University of Marche |
Research Center of Hospital Sacre-Coeur of Montreal |
RIT |
Teschnische Universitat |
The Victor Chang Cardiac Research Institute |
Uniformed Services University |
Universidad Favaloro |
Universita degli Studi di Messina |
Universitat Politecnica de Catalunya (Barcelona-Tech) |
University of Aalborg |
University of Adelaide |
University of Ancona |
University of Bologna |
University of Buffalo |
University of Jena |
University of Ljubjana |
University of Lund |
University of Melbourne Australia |
University of Milano |
University of Minnesota |
University of Munich |
University of Oklahoma |
University of Rochester |
University of San Francisco |
University of Ulster |
University of Utah |
University of Zaragoza |
AMPS LLC |
Angel Medical Systems Inc. |
AstraZeneca |
Biosigna |
BSP Biological Signal Processing LTD |
Cardio-QT Ltd. |
Global Instrumentrations LLC |
iCardiac Technologies Inc. |
Medial Research |
Medtronic Inc. |
Pfizer Inc. |
Philips Healthcare |
Roche |
Samsung Electronics Co. |